Answer
Seretide Accuhaler treats asthma requiring combined inhaled corticosteroid/long-acting β2-agonist therapy in patients inadequately controlled on inhaled corticosteroids plus as-needed inhaled short-acting β2-agonists or adequately controlled on inhaled corticosteroids plus long-acting β2-agonists; 50/100 micrograms is unsuitable for adults and children with severe asthma.
Sources for this answer
- Seretide 100, 250, 500 AccuhalerGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 46Document updated
Sources checked